GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Zhengye Biotechnology
Zhengye Biotechnology's value, like that of any agritech company, will depend on the success of its products, whether fertilizers or veterinary drugs. The potential share price will reflect demand from the agricultural sector and regulatory approvals.
Share prices of companies in the market segment - Agricultural technology
Zhengye Biotechnology specializes in the development, production, and sale of veterinary vaccines for livestock, contributing to food security. We classify it as part of the Agricultural Technology sector. The chart below shows the overall performance of this important segment of the agricultural industry.
Broad Market Index - GURU.Markets
Zhengye Biotechnology is a Chinese company that develops and produces animal vaccines. As a participant in the veterinary market, it is included in our GURU.Markets index. The chart below reflects the overall stock market performance. Compare it with Zhengye shares to assess the industry's prospects.
Change in the price of a company, segment, and market as a whole per day
ZYBT - Daily change in the company's share price Zhengye Biotechnology
Zhengye Biotechnology's daily volatility reflects its extreme sensitivity to news in China's agricultural sector. Change_co for this company is a measure of speculative interest. This metric is important for analyzing risks in the emerging technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Agricultural technology
The agritech sector in which Zhengye Biotechnology operates is highly dynamic. This chart reflects the industry's average volatility. It serves as a benchmark for assessing how sensitive Zhengye's veterinary drug business is to overall trends and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Zhengye Biotechnology is a Chinese company operating in the veterinary pharmaceuticals sector. The country's agricultural sector is heavily dependent on government policy. The chart below shows the volatility in this sector, which helps assess Zhengye's exposure to these factors.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Zhengye Biotechnology
Zhengye Biotechnology's year-over-year performance reflects its position in the Chinese veterinary vaccine market. The company's market capitalization depends on government livestock vaccination programs, particularly against diseases such as foot-and-mouth disease and avian influenza, as well as its ability to develop and commercialize new, effective drugs.
Annual dynamics of market capitalization of the market segment - Agricultural technology
As a private company, Zhengye likely occupies a niche in China's vast agritech market. Its growth depends on its ability to offer innovative products that increase crop yields. Its valuation will reflect trends in Chinese agriculture, potentially outperforming the global sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Zhengye Biotechnology is a Chinese company and is not listed on any major US exchanges. It is impossible to analyze its market performance in the context of the US market. As a producer of animal vaccines, its business is protective, but it is subject to specific agricultural cycles and regulatory risks in China.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Zhengye Biotechnology
Zhengye's performance as a biotech company in the agricultural sector will depend on its product cycle. Monthly fluctuations on the chart will reflect demand for its veterinary vaccines and diagnostic tests, as well as news about new product development.
Monthly dynamics of market capitalization of the market segment - Agricultural technology
Zhengye Biotechnology is an agricultural technology company. It develops solutions to increase crop yields and protect plants, playing a vital role in the food supply chain. The chart below illustrates the overall dynamics of the agritech sector, where innovations are helping address global food security challenges.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Zhengye Biotechnology is a Chinese company operating in the veterinary pharmaceuticals sector. Its shares often move independently of global market trends, responding to domestic agricultural cycles, animal disease outbreaks, and regulatory decisions in China. The chart shows how disconnected the company's performance is from the overall sentiment on global stock markets.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Zhengye Biotechnology
Zhengye Biotechnology, as its name suggests, is associated with agricultural technology in China. The weekly performance of these companies' stocks depends on government agricultural policy, commodity prices, and the introduction of new technologies. The chart will reflect both local and industry trends.
Weekly dynamics of market capitalization of the market segment - Agricultural technology
Zhengye Biotechnology, like other companies in the agtech sector, is dependent on industry-wide factors: crop prices and government agricultural policies. These global trends impact all producers. The chart shows how the company moves in sync with the global agricultural sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Zhengye Biotechnology, operating in the agritech sector, is subject to agricultural cycles and government policy. This chart shows how the company's stock price is detached from the broader market and follows its own agricultural cycle, driven by weather and food demand.
Market capitalization of the company, segment and market as a whole
ZYBT - Market capitalization of the company Zhengye Biotechnology
Data on Zhengye Biotechnology (ZYBT) may be inaccurate, making analysis difficult. A chart for such a company, if it exists, would likely reflect specific trends in China's agtech sector and be subject to high volatility due to regulatory and market risks.
ZYBT - Share of the company's market capitalization Zhengye Biotechnology within the market segment - Agricultural technology
Zhengye Biotechnology is a company whose market share is based on the production of veterinary vaccines and drugs in China. Its market capitalization reflects its role in ensuring the health of farm animals, which is critical to the country's food security.
Market capitalization of the market segment - Agricultural technology
Zhengye Biotechnology operates in the agritech sector. How big is this vital industry? The chart below shows the total market capitalization of the agricultural technology sector. Its growth reflects the global need for innovation to improve crop yields and ensure food security.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Zhengye Biotechnology chart reflects the hopes and risks associated with China's agricultural sector. The market capitalization of this animal vaccine producer depends on the epidemiological situation, government policy, and domestic competition. This diagram illustrates the specifics of doing business in China's agricultural sector.
Book value capitalization of the company, segment and market as a whole
ZYBT - Book value capitalization of the company Zhengye Biotechnology
Zhengye Biotechnology's capital base consists of its production facilities for animal vaccines and diagnostic kits, as well as its R&D laboratories. Its book value reflects the intrinsic value of these agricultural and biotech assets. The chart below shows the dynamics of this production capital.
ZYBT - Share of the company's book capitalization Zhengye Biotechnology within the market segment - Agricultural technology
Zhengye Biotechnology protects animal health, and its strength lies in its modern biopharmaceutical plants. These production facilities create vaccines and diagnostic tests for the agricultural industry. The chart shows the company's control over the production infrastructure in the veterinary biotechnology sector.
Market segment balance sheet capitalization - Agricultural technology
Zhengye Biotechnology likely operates in the agricultural sector. This sector, as the chart shows, is capital-intensive. Its business requires investment in laboratories, animal vaccine production facilities, and other tangible assets.
Book value of all companies included in the broad market index - GURU.Markets
Zhengye Biotechnology's assets include animal vaccine production facilities and research centers. The chart below shows how the company has expanded its production and research capabilities to ensure health in the agricultural sector.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Zhengye Biotechnology
Zhengye Biotechnology owns veterinary drug manufacturing plants. Its market valuation reflects not only these plants but also the growth potential of China's agricultural sector. The chart below shows how the market has assessed these prospects.
Market to book capitalization ratio in a market segment - Agricultural technology
Zhengye Biotechnology is a Chinese company operating in veterinary vaccines and agricultural technology. The chart shows how the market values its technologies and market position in China, comparing its market capitalization with the book value of its production and research centers.
Market to book capitalization ratio for the market as a whole
Zhengye Biotechnology is a Chinese company operating in the veterinary vaccine and drug sector. Its valuation, relative to the market average, depends on its product portfolio, R&D, and the state of agriculture in China. The market evaluates its ability to protect animal health in the vast agribusiness system, not just the value of its factories.
Debts of the company, segment and market as a whole
ZYBT - Company debts Zhengye Biotechnology
Zhengye Biotechnology, a Chinese agritech company, uses capital to finance its operations. This chart shows how the company raises funds to produce veterinary drugs and feed additives. Its financing strategy is influenced by agricultural cycles and government policy in China.
Market segment debts - Agricultural technology
Zhengye Biotechnology, operating in the agritech sector, likely produces animal vaccines or other agricultural biotech products. This business requires investment in research, development, and production capacity. This chart allows us to assess how the company finances its operations and expansion in the specific agribitech market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Zhengye Biotechnology
Zhengye Biotechnology operates in the agricultural technology sector, where innovation requires constant investment. This chart demonstrates the company's use of debt capital to fund research, new product development, and production expansion. It helps assess the financial stability and risks associated with bringing agricultural technologies to market.
Market segment debt to market segment book capitalization - Agricultural technology
Zhengye Biotechnology operates in the agricultural biotechnology sector. This chart shows the debt burden in this sector. It helps understand how companies developing innovative agricultural solutions finance their research and development, and how Zhengye's financial strategy compares to that of global agrochemical giants.
Debt to book value of all companies in the market
Zhengye Biotechnology operates in China's agritech sector. Its financial structure may differ from Western companies. This chart, which reflects the overall debt burden in the US market, provides investors with a comparative basis. It helps assess how conservative or risky the company's debt policy appears against the backdrop of global trends.
P/E of the company, segment and market as a whole
P/E - Zhengye Biotechnology
Zhengye Biotechnology, a Chinese company, specializes in veterinary vaccines and pharmaceuticals for livestock. This chart reflects investor sentiment regarding the growing demand for protein in Asia and the need to protect livestock from disease. The price trend is influenced by government vaccination programs and disease outbreaks, such as African swine fever.
P/E of the market segment - Agricultural technology
Zhengye Biotechnology is a Chinese company operating in the veterinary medicine sector. It develops, produces, and markets animal vaccines to prevent and control diseases in livestock production. This chart shows the average rating for the agritech sector, reflecting the importance of animal health for global food security.
P/E of the market as a whole
Zhengye Biotechnology is a Chinese company specializing in veterinary vaccines. Its valuation depends far more on the state of China's livestock industry and government biosecurity policies than on global market sentiment. This timeframe is less important to the company than news of animal disease outbreaks and regulatory decisions in Beijing.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Zhengye Biotechnology
Zhengye Biotechnology is a Chinese company specializing in the production and sale of veterinary vaccines and pharmaceuticals for animals. This chart reflects expectations for the growth of China's agricultural sector. The company's valuation depends on demand for its products from large livestock farms and government veterinary policy.
%20P%2FE%20Zhengye%20Biotechnology&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Zhengye-Biotechnology&v=1772652838832 "Chart of the company's future (projected) P/E Zhengye Biotechnology")
Future (projected) P/E of the market segment - Agricultural technology
Zhengye Biotechnology operates in the veterinary drug and vaccine sectors, playing a vital role in ensuring the health of farm animals. This chart reflects expectations for the agricultural sector. Comparing its profit forecasts with those of its peers reveals how investors view its product portfolio and position in the agtech market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Agricultural%20technology&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Agricultural-technology&v=1772652838843 "Future (projected) P/E graph of the market segment - Agricultural technology")
Future (projected) P/E of the market as a whole
Zhengye Biotechnology operates in the agritech sector, developing products for livestock farming. Demand for its products is determined by the state of the agricultural sector, food prices, and global demographic trends. This graph of overall market sentiment impacts the agricultural sector indirectly, through the cost of capital and overall economic activity.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772652838844 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Zhengye Biotechnology
Zhengye Biotechnology is a company operating in the agricultural technology sector. Its financial success depends on the implementation of innovative solutions in agriculture, whether biotechnology or veterinary drugs. This chart shows the company's path to profitability, which is determined by the effectiveness of its products and demand from the agricultural sector.
Profit of companies in the market segment - Agricultural technology
Zhengye Biotechnology operates in the agricultural technology sector, producing veterinary drugs and vaccines. The company contributes to food security, and its business depends on the health of the livestock sector. This chart shows overall profitability in the agricultural sector, which is influenced by raw material prices, animal health risks, and government agricultural policies.
Overall market profit
Zhengye Biotechnology, working in agricultural technology, contributes to increasing the efficiency and sustainability of the agricultural sector. Innovations in this field help ensure food security and optimize farmers' costs. A healthy agricultural sector is the foundation for stable consumer prices and an important part of the real economy.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Zhengye Biotechnology
Zhengye Biotechnology specializes in veterinary vaccines for farm animals in China. This chart reflects expectations for the country's livestock industry. Disease outbreaks, government policies, and farm consolidation directly impact demand and future profits.
%20profit%20of%20the%20company%20Zhengye%20Biotechnology&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Zhengye-Biotechnology&v=1772652838864 "Graph of future (projected) profit of the company Zhengye Biotechnology")
Future (predicted) profit of companies in the market segment - Agricultural technology
Zhengye Biotechnology develops and produces animal vaccines. This chart shows general profitability expectations for the veterinary pharmaceutical and agritech sector. It helps assess how growing global demand for animal protein and the need to protect livestock from disease impact the company's prospects.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Agricultural%20technology&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Agricultural-technology&v=1772652838867 "Graph of future (predicted) profits of companies in a market segment - Agricultural technology")
Future (predicted) profit of the market as a whole
The dynamics in this chart reflect expectations for a Chinese company operating in veterinary biotechnology. Zhengye Biotechnology's profit forecast depends on demand for animal vaccines from China's agricultural sector. Livestock disease outbreaks and government agricultural policies significantly impact results.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772652838869 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Zhengye Biotechnology
Zhengye Biotechnology, operating in China's agricultural sector, has enormous growth potential, but also corresponding risks. This chart shows how investors estimate its revenue, adjusted for regulatory and geopolitical factors. It balances the prospects for modernizing China's agriculture with uncertainty.
P/S market segment - Agricultural technology
Zhengye Biotechnology develops and sells animal vaccines, contributing to food security. The company's revenue is directly dependent on demand in the agricultural sector. This chart reflects the average valuation in the agtech sector, helping investors understand how the market values the company's contribution to livestock health compared to other producers.
P/S of the market as a whole
Zhengye Biotechnology develops and produces animal vaccines, playing a vital role in ensuring livestock health. The company's revenue is driven by demand in the agricultural sector. This graph, which displays average revenue estimates, helps understand the market's perception of the agtech sector's prospects and the importance of disease prevention in livestock production.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Zhengye Biotechnology
Zhengye Biotechnology develops and produces animal vaccines. The company's future revenue depends on demand for its products from livestock farmers, which, in turn, is linked to food security and disease prevention. This chart reflects the market's assessment of growth prospects in the agritech sector.
%20P%2FS%20Zhengye%20Biotechnology&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Zhengye-Biotechnology&v=1772652838878 "The graph of the company's future (projected) P/S Zhengye Biotechnology")
Future (projected) P/S of the market segment - Agricultural technology
Zhengye Biotechnology likely operates in the agricultural biotechnology sector in China. This chart compares the company's estimated future revenue with other agritech firms. It reflects investor expectations for its products, whether animal vaccines or other biotech solutions, and their potential in the vast Asian market.
%20P%2FS%20market%20segment%20graph%20-%20Agricultural%20technology&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Agricultural-technology&v=1772652838880 "Future (projected) P/S market segment graph - Agricultural technology")
Future (projected) P/S of the market as a whole
Zhengye Biotechnology operates in the veterinary drug and vaccine sector in China. Its business depends on the state of the agricultural sector and food security measures. The company's growth is an indicator of the development of the Asian agricultural sector, which contributes to the global forecasts shown in this chart.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772652838885 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Zhengye Biotechnology
Zhengye Biotechnology operates in the agritech sector, likely specializing in livestock or crop products for the Chinese market. This chart is intended to demonstrate the commercial success of its products. Its growth will reflect farm demand for its crop-improving or livestock health solutions.
Sales of companies in the market segment - Agricultural technology
Zhengye Biotechnology specializes in the development and production of animal vaccines, playing a vital role in ensuring livestock health and food security. Demand for its products depends on the state of the agricultural sector. This chart shows overall sales in the sector, illustrating the scale and dynamics of the veterinary drug and agricultural technology market.
Overall market sales
Zhengye Biotechnology operates in the agricultural technology sector, producing veterinary drugs and vaccines for livestock. This overall economic activity pattern impacts the company through the agricultural sector. Growing global demand for food and protein encourages farmers to invest in livestock health and productivity, increasing demand for Zhengye products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Zhengye Biotechnology
Zhengye Biotechnology specializes in the development and production of animal vaccines. The company's future revenue depends on demand from the agricultural sector, particularly livestock farms, and the global epidemiological situation. This chart reflects analysts' forecasts for agricultural sector growth and the need to ensure the health of farm animals.
%20sales%20of%20the%20company%20Zhengye%20Biotechnology&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Zhengye-Biotechnology&v=1772652838938 "Schedule of future (projected) sales of the company Zhengye Biotechnology")
Future (projected) sales of companies in the market segment - Agricultural technology
Zhengye Biotechnology specializes in veterinary drugs and vaccines for livestock. This chart shows projected revenue for the entire agritech sector. It reflects expectations for growth in the livestock industry and demand for livestock health products, a key market for the company.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Agricultural%20technology&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Agricultural-technology&v=1772652838942 "Schedule of future (projected) sales of companies in the market segment - Agricultural technology")
Future (projected) sales of the market as a whole
Zhengye Biotechnology operates in agricultural technology, specifically animal vaccines. Demand for its products depends on the state of the agricultural sector and food prices. This trend, reflecting global economic trends, impacts food demand and, consequently, the income of farms, the company's primary clients.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772652838944 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Zhengye Biotechnology
Zhengye Biotechnology operates in the agricultural technology sector, producing veterinary drugs. The company's profitability, illustrated by this chart, depends on its production efficiency, research expenditures, and product demand from livestock farmers. This is an indicator of how scientific research translates into commercial success.
Market segment marginality - Agricultural technology
Zhengye Biotechnology operates in the agricultural technology sector in China, developing animal health products. Success in this sector means the ability to create marketable and cost-effective solutions for the agricultural industry. This chart shows how the company compares to other players, reflecting its scientific potential and commercial success.
Market marginality as a whole
Zhengye Biotechnology operates in the agricultural technology sector, developing animal health products. The company's profitability depends on innovation, the effectiveness of its products, and demand from the agricultural sector. This total market return chart highlights how Zhengye operates in a sector driven by global food demand trends rather than short-term economic cycles.
Employees in the company, segment and market as a whole
Number of employees in the company Zhengye Biotechnology
Zhengye Biotechnology specializes in the development and production of animal vaccines. The team size, shown in this chart, demonstrates the human capital involved in research, production, and quality control. The growth in staff indicates an increase in production capacity and the expansion of the livestock health product line.
Share of the company's employees Zhengye Biotechnology within the market segment - Agricultural technology
This indicator reflects Zhengye Biotechnology's niche in the agricultural sector. The company's workforce in this sector is focused on the development and production of animal vaccines. This team of veterinary scientists and specialists creates products to protect farm animals from various diseases, promoting food security and livestock health.
Number of employees in the market segment - Agricultural technology
Zhengye Biotechnology operates in the agritech sector, developing animal health products. Improving agricultural efficiency is a global challenge that requires scientific innovation. This graph illustrates how modern agricultural enterprises are becoming increasingly science-intensive, creating a demand for veterinarians, biologists, and geneticists.
Number of employees in the market as a whole
Zhengye Biotechnology Holding Co., Ltd. operates in the veterinary drug sector. Demand for its products depends on the health and size of livestock, which is linked to global food demand rather than the current work schedule. The company ensures food security, a long-term, non-cyclical trend.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Zhengye Biotechnology (ZYBT)
Zhengye Biotechnology is a Chinese company operating in agricultural biotechnology. This chart, presented for a US exchange, allows us to assess how US investors perceive its intellectual capital. A high value may indicate confidence in its patents and scientific developments, which could improve agricultural yields and efficiency.
%20of%20the%20company%20Zhengye%20Biotechnology%20(ZYBT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Zhengye-Biotechnology-ZYBT&v=1772652839026 "Chart of market capitalization per employee (in thousands of dollars) of the company Zhengye Biotechnology (ZYBT)")
Market capitalization per employee (in thousands of dollars) in the market segment - Agricultural technology
Zhengye Biotechnology operates in the agro-tech sector, developing veterinary drugs. The company's value is determined by its scientific developments. This indicator reflects how the market evaluates its product portfolio and research potential per employee, which is a measure of innovation.
%20by%20market%20segment%20-%20Agricultural%20technology&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Agricultural-technology&v=1772652839042 "Market capitalization per employee (in thousands of dollars) by market segment - Agricultural technology")
Market capitalization per employee (in thousands of dollars) for the overall market
Zhengye Biotechnology, as its name suggests, is involved in agricultural biotechnology. This chart for such a company would reflect the market's assessment of its R&D and potential for increasing crop yields or protecting plants. A high ratio per employee would indicate the value of its intellectual property, not the scale of its production.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772652839050 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Zhengye Biotechnology (ZYBT)
Zhengye Biotechnology is a Chinese company specializing in veterinary drugs, specifically vaccines for livestock. This chart shows the profitability of the agro-biotech sector. Success here depends on R&D and the ability to produce effective vaccines to protect livestock, which is critical for food security.
%20Chart%20Zhengye%20Biotechnology%20(ZYBT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Zhengye-Biotechnology-ZYBT&v=1772652839054 "Company Profit Per Employee (in thousands of dollars) Chart Zhengye Biotechnology (ZYBT)")
Profit per employee (in thousands of dollars) in the market segment - Agricultural technology
Zhengye Biotechnology operates in the agritech sector, likely focusing on animal health or veterinary pharmaceuticals. This chart shows how effectively the company's employees develop and commercialize in-demand agritech products. It reflects the industry average, serving as a benchmark for assessing Zhengye's competitiveness and operational efficiency.
%20in%20the%20market%20segment%20-%20Agricultural%20technology&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Agricultural-technology&v=1772652839057 "Chart of profit per employee (in thousands of dollars) in the market segment - Agricultural technology")
Profit per employee (in thousands of dollars) for the market as a whole
Zhengye Biotechnology (ZYBT) specializes in veterinary drugs and vaccines for livestock. It combines R&D and manufacturing. This chart shows the profitability of their product portfolio. High profit per employee may be due to the availability of in-demand, high-margin vaccines or efficient automated production requiring minimal human intervention.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772652839071 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Zhengye Biotechnology (ZYBT)
Zhengye Biotechnology operates in the agritech sector. This chart shows how the company applies scientific research to agriculture. The growth in revenue per employee reflects the successful commercialization of products such as animal vaccines and feed additives, which improve the efficiency of agribusiness.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Zhengye-Biotechnology-ZYBT&v=1772652839092 "Sales chart per company employee Zhengye Biotechnology (ZYBT)")
Sales per employee in the market segment - Agricultural technology
Zhengye Biotechnology appears to operate in the veterinary pharmaceuticals or agritech sector in China. This chart shows the average revenue per employee in this segment. It allows us to assess how productive this company is in its niche compared to other players in the agritech or biotech sector.
Sales per employee for the market as a whole
Zhengye Biotechnology is a Chinese company specializing in veterinary drugs and vaccines for livestock. It's biotechnology, but for the agricultural sector. This chart shows how their R&D team and production facilities create products critical for protecting livestock and poultry in industrial animal agriculture.
Short shares by company, segment and market as a whole
Shares shorted by company Zhengye Biotechnology (ZYBT)
Zhengye Biotechnology is a Chinese company operating in the agritech sector. The bearish sentiment seen on this chart is often related less to the business than to jurisdictional risks. Bears point to the lack of transparency in Chinese companies' reporting, regulatory pressure from Beijing, and geopolitical risks (delisting from US exchanges).
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Zhengye-Biotechnology-ZYBT&v=1772652839127 "Short Shares Chart for the Company Zhengye Biotechnology (ZYBT)")
Shares shorted by market segment - Agricultural technology
Zhengye Biotechnology is a Chinese company focused on veterinary biopharmaceuticals, including animal vaccines. This chart shows the overall sentiment in the sector. It reflects investor concerns about risks in the agricultural sector, possibly related to animal disease outbreaks or regulatory pressure in Asia.
Shares shorted by the overall market
Zhengye Biotechnology is a Chinese company that produces animal vaccines. This business combines the risks of the agricultural sector (disease outbreaks) with the regulatory risks of China. When this indicator of *global* market pessimism rises, investors tend to sell the riskiest and most opaque emerging market stocks first.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Zhengye Biotechnology (ZYBT)
Zhengye Biotechnology (ZYBT) is a Chinese animal health company. They produce vaccines and veterinary drugs for pigs, poultry, and cattle. This chart measures momentum. It shows "overheating" (above 70) amid disease outbreaks (such as African swine fever), which boosts demand for vaccines, or "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Zhengye-Biotechnology-ZYBT&v=1772652839296 "RSI 14 indicator chart for the company's stock Zhengye Biotechnology (ZYBT)")
RSI 14 Market Segment - Agricultural technology
Zhengye Biotechnology (ZYBT) is a Chinese company specializing in veterinary drugs and vaccines for livestock. This chart tracks sentiment in the AgTech sector. It helps distinguish between ZYBT-specific risks in China (such as disease outbreaks) and general overheating or overselling in the global agricultural sector.
RSI 14 for the overall market
Zhengye Biotechnology (ZYBT), a Chinese maker of animal vaccines. This chart reflects both country risk and the "defensive" sector. Investors are fleeing China in panic. However, the business itself (livestock health) is "defensive"—it depends on disease cycles, not the economy, creating a mixed picture for ZYBT.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ZYBT (Zhengye Biotechnology)
Zhengye Biotechnology (ZYBT) is a Chinese company specializing in the development, production, and sale of vaccines and diagnostic tests for livestock. This chart shows the average target price from analysts. It reflects their assessment of animal protein demand in Asia, the risk of disease outbreaks, and the regulatory environment in China.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ZYBT-Zhengye-Biotechnology&v=1772652839402 "A chart showing analyst consensus forecasts for the expected stock price. ZYBT (Zhengye Biotechnology)")
The difference between the consensus estimate and the actual stock price ZYBT (Zhengye Biotechnology)
Zhengye Biotechnology (ZYBT) is a Chinese company specializing in veterinary vaccines and diagnostics for livestock. This chart is a barometer of the Chinese agricultural sector. It measures the gap between the price and the consensus target, reflecting the potential (or risk) analysts see in their ability to ensure food security.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ZYBT-Zhengye-Biotechnology&v=1772652839428 "A chart showing the difference between the consensus forecast and the actual stock price. ZYBT (Zhengye Biotechnology)")
Analyst consensus forecast for stock prices by market segment - Agricultural technology
Zhengye Biotechnology (ZYBT) is a Chinese company specializing in animal health, specifically the development and production of livestock vaccines. This chart shows analysts' overall expectations for the entire agtech sector. It reflects whether experts believe demand for protein (meat) and, consequently, veterinary drugs will grow, or whether they anticipate a decline in livestock production.
Analysts' consensus forecast for the overall market share price
Zhengye Biotechnology is a Chinese company specializing in the development and production of animal vaccines, primarily for the pig and poultry industries. This chart shows the overall sentiment of the *global* market. For Zhengye, whose business depends on agricultural cycles in Asia, general investor optimism often takes a backseat to specific risks (such as animal disease outbreaks).
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Zhengye Biotechnology
Zhengye Biotechnology (ZYBT) is a Chinese company operating in agritech. They likely specialize in the production of animal vaccines and other biotech products for agriculture. This chart is a barometer of Chinese agriculture. Its dynamics reflect the demand for their products (which depends on the health of livestock in China) and the regulatory risks associated with doing business in China.
AKIMA Market Segment Index - Agricultural technology
Zhengye Biotechnology (ZYBT) is a Chinese biotechnology company focused on animal health; the company produces and sells vaccines for livestock (pigs, poultry). This comprehensive index evaluates companies. The chart shows the average value for the sector. This benchmark provides insight into how this niche (veterinary vaccines) and geographic (China) model (ZYBT) differentiates it from the average competitor.
The AKIM Index for the overall market
Zhengye Biotechnology is a Chinese company operating in veterinary medicine and producing livestock vaccines. It's betting on China's agricultural sector. This chart, showing the average (global/US) market value, serves as a benchmark. It helps assess how this niche company stacks up against overall macroeconomic trends.
